Literature DB >> 19380217

A cross-over response to sequential use of sunitinib after sorafenib in a patient with metastatic renal cell carcinoma.

T M Richards, P N Plowman, R Reznek, S A Ball.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19380217     DOI： 10.1016/j.clon.2009.03.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  1 in total

1.  Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma.

Authors:  Hee Kyung Ahn; Soohyeon Lee; Jong-Mu Sun; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Won Ki Kang; Ho Yeong Lim
Journal:  Invest New Drugs       Date:  2011-07-01       Impact factor: 3.651
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.